Tetracycline Dosing for Urinary Tract Infection
For an adult with a tetracycline-sensitive urinary tract infection, the recommended dose is 500 mg orally four times daily for at least 7 days.
Dosing Recommendation
The FDA-approved dosing for tetracycline in urinary tract infections is clearly specified in the drug label 1:
- Standard UTI dosing: 500 mg orally four times daily (every 6 hours) for at least 7 days
- Alternative: 1 gram daily as 500 mg twice daily or 250 mg four times daily for general infections, though the higher frequency dosing is preferred for UTIs
Important administration considerations 1:
- Take with adequate fluid to reduce esophageal irritation risk
- Avoid taking with antacids containing aluminum, calcium, or magnesium
- Avoid concurrent iron, zinc, or sodium bicarbonate preparations
- Take on an empty stomach as food and dairy products impair absorption
Evidence Supporting This Recommendation
While single-dose tetracycline (2 g) showed 75% cure rates in one older study 2, the FDA-approved regimen remains the standard. The single-dose study demonstrated efficacy but multi-dose therapy (500 mg four times daily for 10 days) achieved superior cure rates of 94% 2.
Clinical Context
Tetracycline is rarely first-line for UTIs in contemporary practice. Modern guidelines for uncomplicated UTIs recommend fluoroquinolones, nitrofurantoin, or trimethoprim-sulfamethoxazole as preferred agents 3. However, when susceptibility testing confirms tetracycline sensitivity and other options are contraindicated or unavailable, this dosing regimen is appropriate.
Key Contraindications and Warnings
From the acne vulgaris guidelines (which provide comprehensive tetracycline safety data) 4:
- Absolute contraindication: Hypersensitivity to any tetracycline
- Pregnancy category D: Contraindicated in pregnancy
- Nursing: Distributed into breast milk; discontinue nursing or the drug
- Pediatric: Should not be used in children <8 years due to permanent tooth discoloration and enamel hypoplasia
Common adverse effects to monitor 4:
- Gastrointestinal: nausea, vomiting, diarrhea, esophagitis
- Photosensitivity reactions
- Dose-related rise in blood urea nitrogen (monitor in renal impairment)
Renal Dosing Adjustment
Critical: In patients with renal impairment, decrease total dosage by reducing individual doses and/or extending intervals between doses 1. Specific adjustments should be based on creatinine clearance.